dx.doi.org/10.1182/bloodadvances.2020002512, hdl.handle.net/1765/131653
Blood Advances
Department of Hematology

Vadakekolathu, J., Lai, C, Reeder, S., Church, S.E., Hood, T., Lourdusamy, A, … Rutella, S. (2020). TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML. Blood Advances, 4(20), 5011–5024. doi:10.1182/bloodadvances.2020002512